Researchers conducted a safety and efficacy study that included ten patients with a median age of 50 years with COVID-19-induced acute respiratory distress syndrome (ARDS).
[Journal of Cellular and Molecular Medicine]
6445212
AAAAAAAA
items
1
apa
0
default
asc
1
167690
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
